Document is current
Any future updates will be listed below
-
Authors
Brandi, Maria Luisa https://orcid.org/0000-0002-8741-0592
Vainicher, Cristina Eller
Fintini, Danilo
Giusti, Andrea
Magnolato, Andrea
Minisola, Salvatore
Giannini, Sandro
-
Funding
Funding for this research was provided by:
Kyowa Kirin Farmacéutica (Kyowa Kirin Farmacéutica)
- License Information
-
More Information
Article History
Received: 25 June 2024
Accepted: 24 July 2025
First Online: 7 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: MLB declares honoraria from Amgen, Ascendis, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, UCB, grants and/or speaker fees from Abiogen, Alexion, Amgen, Amolyt, Amorphical, Bruno Farmaceutici, CoGeDi, Echolight, Eli Lilly, Enterabio, Gedeon Richter, Italfarmaco, Kyowa Kirin, Menarini, Monte Rosa Therapeutics, SPA, Takeda, Theramex, UCB, and consultant fees from Aboca, Alexion, Amolyt, Brun Farmaceutici, Calcilytix, Echolight, Kyowa Kirin, Personal Genomics, Smoke Free World Foundation; CEV declares speaker and/or consulting fees from Kyowa Kirin; AG declares speaker and/or consulting fees from Kyowa Kirin, AMGEN, UCB, Abiogen, Latin Pharma; SM served as speaker for Abiogen, Beijing Society Biomedical Engineering, Bruno Farmaceutici, Diasorin, Geopharma, Sandoz, UCB and served in the advisory board of Abiogen, Ely Lilli, Kyowa Kirin, Faes Farm., Novo Nordisk, UCB; DF, AM and SG report no conflict of interest.
